You are here

Pharma CEOs

J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs

Endpoints

Thu, 03/14/19 - 11:15 pm

Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a crossroads

Endpoints

Thu, 03/14/19 - 11:13 pm

Lilly CEO David Ricks snags $17.2M pay package for 2018, a 9% hike

Fierce Pharma

Wed, 03/13/19 - 11:22 pm

Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs

Endpoints

Wed, 03/13/19 - 10:23 am

Two big pharma execs share the same challenges, but compensation? They’re not even close

Endpoints

Mon, 03/11/19 - 10:04 am

Richard Gonzalez

Olivier Brandicourt

What do Allergan activists really want? A new CEO to replace Saunders, analyst says

Fierce Pharma

Tue, 03/5/19 - 12:03 pm

Bad year at Celgene? Forget about it. CEO Mark Alles nabbed a big raise as compensation gyrated to $16.2M

Endpoints

Tue, 03/5/19 - 12:02 pm

Was AstraZeneca CEO Pascal Soriot happy with his $14.8M in '18 compensation? Probably not so much

Endpoints

Tue, 03/5/19 - 12:01 pm

Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs

Fierce Pharma

Fri, 03/1/19 - 08:28 pm

Under-pressure Allergan backs a CEO-chairman job split—just not right now

Fierce Pharma

Tue, 02/19/19 - 11:28 pm

AZ’s CEO dismisses “fake news” about his imminent departure

Pharmaforum

Thu, 02/14/19 - 12:00 pm

Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns

Fierce Pharma

Wed, 02/13/19 - 11:49 am

Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White

Forbes

Wed, 02/13/19 - 11:22 am

Novartis CEO lauds Trump administration plan to overhaul rebates

Yahoo/Reuters

Thu, 02/7/19 - 09:40 am

Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day

Fierce Pharma

Tue, 02/5/19 - 10:00 am

Gilead Sciences

As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices

BioSpace

Wed, 01/30/19 - 07:05 pm

CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity

Stat

Mon, 01/28/19 - 10:08 am

Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech

Endpoints

Thu, 01/24/19 - 11:50 am

Alexander Hardy

Has Abbott's Acquisitive Miles White Made His Last Big Deal?

Forbes

Wed, 01/23/19 - 07:56 pm

Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard

Forbes

Thu, 01/17/19 - 12:04 am

Pages